BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $307,000 | +6.6% | 3,581 | 0.0% | 0.04% | +2.7% |
| Q3 2021 | $288,000 | 0.0% | 3,581 | 0.0% | 0.04% | +5.7% |
| Q2 2021 | $288,000 | -7.7% | 3,581 | -3.2% | 0.04% | -12.5% |
| Q1 2021 | $312,000 | +2.3% | 3,700 | -2.6% | 0.04% | 0.0% |
| Q4 2020 | $305,000 | -0.3% | 3,800 | 0.0% | 0.04% | -14.9% |
| Q3 2020 | $306,000 | -7.3% | 3,800 | -0.7% | 0.05% | -11.3% |
| Q2 2020 | $330,000 | +6.1% | 3,827 | 0.0% | 0.05% | -10.2% |
| Q1 2020 | $311,000 | +1.3% | 3,827 | +4.1% | 0.06% | +37.2% |
| Q4 2019 | $307,000 | -4.4% | 3,675 | 0.0% | 0.04% | -14.0% |
| Q3 2019 | $321,000 | +6.6% | 3,675 | 0.0% | 0.05% | +31.6% |
| Q2 2019 | $301,000 | +0.7% | 3,675 | 0.0% | 0.04% | -9.5% |
| Q1 2019 | $299,000 | +23.0% | 3,675 | -0.6% | 0.04% | +2.4% |
| Q4 2018 | $243,000 | -14.7% | 3,697 | 0.0% | 0.04% | -2.4% |
| Q3 2018 | $285,000 | +2.2% | 3,697 | -2.1% | 0.04% | -17.6% |
| Q2 2018 | $279,000 | +7.3% | 3,775 | -5.5% | 0.05% | +8.5% |
| Q1 2018 | $260,000 | +0.8% | 3,995 | 0.0% | 0.05% | +2.2% |
| Q4 2017 | $258,000 | -36.8% | 3,995 | -38.5% | 0.05% | -37.8% |
| Q3 2017 | $408,000 | -10.7% | 6,495 | -13.9% | 0.07% | -39.3% |
| Q2 2017 | $457,000 | -68.2% | 7,545 | -80.0% | 0.12% | -79.8% |
| Q4 2015 | $1,437,000 | -28.1% | 37,666 | -38.1% | 0.60% | -27.3% |
| Q3 2015 | $1,999,000 | -70.5% | 60,863 | -37.2% | 0.83% | -68.1% |
| Q2 2015 | $6,781,000 | +1.2% | 96,972 | -0.9% | 2.60% | +33.7% |
| Q1 2015 | $6,702,000 | -5.1% | 97,835 | +1.5% | 1.95% | +3.7% |
| Q4 2014 | $7,061,000 | +4.9% | 96,343 | +2.8% | 1.88% | -6.5% |
| Q3 2014 | $6,728,000 | +3.9% | 93,742 | +4.7% | 2.01% | -0.8% |
| Q2 2014 | $6,476,000 | -1.3% | 89,567 | +0.5% | 2.02% | -4.9% |
| Q1 2014 | $6,561,000 | +14.3% | 89,165 | +8.0% | 2.13% | +14.8% |
| Q4 2013 | $5,741,000 | +21.1% | 82,546 | +14.4% | 1.86% | +19.8% |
| Q3 2013 | $4,739,000 | -5.6% | 72,144 | -0.4% | 1.55% | -14.8% |
| Q2 2013 | $5,020,000 | – | 72,468 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |